Skip to main content
. 2020 Oct 7;371:m3503. doi: 10.1136/bmj.m3503

Fig 2.

Fig 2

Adjusted mean differences between treatment group (purple line) and control group (bold black line) follow‐up quality of life scores from expanded prostate cancer index composite short form, EPIC-26. Controls are the reference group (adjusted mean difference=0). Shading indicates the region outside of which adjusted mean differences exceed the minimally important difference. Minimally important difference limits are calculated as plus or minus one third of the pooled baseline standard deviation of the control group and of the treatment group. Adjusted mean differences are adjusted for baseline age, marital status, having private health insurance, region of residence, income, education, country of birth, comorbidity score, and domain-specific baseline (year 0) quality of life score